These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22967411)

  • 1. [Clinical features and survival analysis in primary myelodysplastic syndromes patients with immunological abnormalities].
    Li B; Xu ZF; Cui R; Chen YD; Su T; Zhang TJ; Fang LW; Zhang HL; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):527-31. PubMed ID: 22967411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of clinical features and prognosis of primary myelodysplastic syndromes with myelofibrosis patients].
    Su T; Zhang PH; Xu ZF; Chen HS; Qin TJ; Zhang Y; Zhang HL; Fan LW; Pan LJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):378-82. PubMed ID: 22781796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low C3 levels is associated with neutropenia in a proportion of patients with myelodysplastic syndrome: retrospective analysis.
    Kim KJ; Kwok SK; Park YJ; Kim WU; Cho CS
    Int J Rheum Dis; 2012 Feb; 15(1):86-94. PubMed ID: 22324951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.
    Kao JM; McMillan A; Greenberg PL
    Am J Hematol; 2008 Oct; 83(10):765-70. PubMed ID: 18645988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on prognostic significances of different cytogenetic risk categories in patients with primary myelodysplastic syndromes].
    Qu SQ; Liu XP; Xu ZF; Zhang Y; Qin TJ; Zhang TJ; Cui R; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):819-24. PubMed ID: 22339954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between myelodysplastic syndromes and autoimmune disorders.
    Zhao S; Mao H; Wang H; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.
    Huang TC; Ko BS; Tang JL; Hsu C; Chen CY; Tsay W; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
    Leukemia; 2008 Mar; 22(3):544-50. PubMed ID: 18094713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.
    Giannouli S; Voulgarelis M; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    Rheumatology (Oxford); 2004 May; 43(5):626-32. PubMed ID: 14983106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
    Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS
    Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome.
    Lee JH; Lee JH; Shin YR; Lee JS; Kim WK; Chi HS; Park CJ; Seo EJ; Lee KH
    Leukemia; 2003 Feb; 17(2):305-13. PubMed ID: 12592327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome.
    Cordoba I; Gonzalez-Porras JR; Such E; Nomdedeu B; Luño E; de Paz R; Carbonell F; Vallespi T; Ardanaz M; Ramos F; Marco V; Bonanad S; Sanchez-Barba M; Costa D; Bernal T; Sanz GF; Cañizo MC
    Leuk Res; 2012 Mar; 36(3):287-92. PubMed ID: 22133642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan.
    Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
    Leukemia; 1993 Apr; 7(4):499-508. PubMed ID: 8464227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.
    Valcárcel D; Ademà V; Solé F; Ortega M; Nomdedeu B; Sanz G; Luño E; Cañizo C; de la Serna J; Ardanaz M; Marco V; Collado R; Grau J; Montoro J; Mallo M; Vallespí T
    J Clin Oncol; 2013 Mar; 31(7):916-22. PubMed ID: 23319689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A preliminary study of prognostic value of thrombocytopenia in patients with primary myelodysplastic syndromes].
    Chen YD; Xu ZF; Cui R; Wang JY; Zhang TJ; Fang LW; Zhang HL; Qin TJ; Zhang Y; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):532-5. PubMed ID: 22967412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of patients with aplastic anemia or myelodysplastic syndrome associated with persistent neutropenia.
    Kako S; Nakasone H; Endo H; Sakamoto K; Ashizawa M; Sato M; Terasako K; Kikuchi M; Kimura S; Okuda S; Yamazaki R; Oshima K; Tanihara A; Nishida J; Usuki K; Kanda Y
    Hematol Oncol; 2012 Jun; 30(2):82-8. PubMed ID: 21692099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
    Saumell S; Florensa L; Luño E; Sanzo C; Cañizo C; Hernández JM; Cervera J; Gallart MA; Carbonell F; Collado R; Arenillas L; Pedro C; Bargay J; Nomdedeu B; Xicoy B; Vallespí T; Raya JM; Belloch L; Sanz GF; Solé F
    Br J Haematol; 2012 Nov; 159(3):311-21. PubMed ID: 22958186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.